The first assay marketed in 2000 used a defined peptide from filaggrin, the citrullinated autoantigen in anti-keratin antibodies (24), and the first protein to be used as a citrullinated autoantigen in RA studies (7, 8). This evidence concerns the gene FLG and rheumatoid arthritis.